| neutral lipid metabolic process | GO:0006638 | 57 | 0.876 | |
| hemostasis | GO:0007599 | 78 | 0.790 | |
| negative regulation of fibrinolysis | GO:0051918 | 1 | 0.750 | |
| fibrinolysis | GO:0042730 | 3 | 0.740 | Human |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.713 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.700 | Human Mouse |
| coagulation | GO:0050817 | 78 | 0.698 | |
| sterol metabolic process | GO:0016125 | 58 | 0.644 | |
| protein processing | GO:0016485 | 163 | 0.579 | Human |
| blood circulation | GO:0008015 | 195 | 0.560 | |
| circulatory system process | GO:0003013 | 197 | 0.559 | |
| protein lipid complex subunit organization | GO:0071825 | 12 | 0.538 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.504 | |
| wound healing | GO:0042060 | 157 | 0.494 | |
| blood coagulation | GO:0007596 | 76 | 0.493 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.490 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.460 | |
| positive regulation of protein kinase c activity | GO:1900020 | 1 | 0.440 | |
| steroid metabolic process | GO:0008202 | 119 | 0.436 | |
| negative regulation of coagulation | GO:0050819 | 11 | 0.423 | Human Mouse |
| hexose metabolic process | GO:0019318 | 98 | 0.420 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.418 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.418 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.416 | |
| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 0.412 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.411 | |
| negative regulation of hemostasis | GO:1900047 | 11 | 0.403 | Human Mouse |
| lipid biosynthetic process | GO:0008610 | 179 | 0.400 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.384 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.371 | Human Mouse |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.370 | |
| negative regulation of blood coagulation | GO:0030195 | 11 | 0.370 | Human Mouse |
| amine metabolic process | GO:0009308 | 45 | 0.367 | |
| positive regulation of plasminogen activation | GO:0010756 | 2 | 0.363 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.361 | |
| extracellular structure organization | GO:0043062 | 148 | 0.360 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.341 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.325 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.320 | |
| cofactor transport | GO:0051181 | 4 | 0.313 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.304 | Human |
| gland development | GO:0048732 | 330 | 0.302 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.301 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.288 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.287 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.284 | |
| regulation of fibrinolysis | GO:0051917 | 1 | 0.281 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.274 | |
| protein maturation | GO:0051604 | 176 | 0.261 | Human |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.247 | |
| regulation of system process | GO:0044057 | 200 | 0.247 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.247 | |
| regulation of secretion | GO:0051046 | 274 | 0.244 | |
| lipid homeostasis | GO:0055088 | 63 | 0.240 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.240 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.236 | Human Mouse |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.235 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.232 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.232 | Human |
| regulation of protein maturation | GO:1903317 | 96 | 0.231 | Human |
| skeletal system development | GO:0001501 | 356 | 0.228 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.221 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.219 | |
| glucose metabolic process | GO:0006006 | 92 | 0.217 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.213 | |
| regulation of wound healing | GO:0061041 | 40 | 0.212 | Human Mouse |
| oxidation reduction process | GO:0055114 | 342 | 0.211 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.209 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.203 | |
| response to hypoxia | GO:0001666 | 58 | 0.202 | |
| positive regulation of fatty acid biosynthetic process | GO:0045723 | 3 | 0.200 | |
| lipid localization | GO:0010876 | 126 | 0.197 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.195 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.190 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.189 | |
| inflammatory response | GO:0006954 | 244 | 0.189 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.186 | |
| regulation of intestinal cholesterol absorption | GO:0030300 | 4 | 0.184 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.184 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.183 | Human |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.183 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.182 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.182 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.178 | |
| ovarian follicle rupture | GO:0001543 | 2 | 0.177 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.175 | |
| rhythmic process | GO:0048511 | 174 | 0.174 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.168 | |
| cell adhesion | GO:0007155 | 329 | 0.162 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.158 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.157 | |
| regulation of plasminogen activation | GO:0010755 | 4 | 0.154 | |
| female sex differentiation | GO:0046660 | 84 | 0.152 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.151 | |
| muscle contraction | GO:0006936 | 101 | 0.150 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.148 | |
| regulation of protein processing | GO:0070613 | 96 | 0.147 | Human |
| regulation of transferase activity | GO:0051338 | 263 | 0.146 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.145 | Human |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.144 | Human |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.143 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.141 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.140 | |
| naphthalene metabolic process | GO:0018931 | 1 | 0.140 | |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.137 | |
| astrocyte differentiation | GO:0048708 | 43 | 0.137 | Human |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.133 | |
| fat soluble vitamin metabolic process | GO:0006775 | 11 | 0.133 | |
| zymogen activation | GO:0031638 | 41 | 0.133 | |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.131 | |
| renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure | GO:0003072 | 5 | 0.129 | |
| mapk cascade | GO:0000165 | 281 | 0.129 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.126 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.126 | |
| ceramide metabolic process | GO:0006672 | 31 | 0.125 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.125 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.124 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.122 | |
| angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001998 | 3 | 0.119 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.118 | |
| response to oxygen levels | GO:0070482 | 62 | 0.118 | |
| response to metal ion | GO:0010038 | 47 | 0.117 | |
| ossification | GO:0001503 | 216 | 0.116 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.114 | |
| muscle system process | GO:0003012 | 141 | 0.114 | |
| ovulation cycle | GO:0042698 | 59 | 0.111 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.110 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.109 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.108 | |
| cellular homeostasis | GO:0019725 | 240 | 0.107 | Human |
| regulation of systemic arterial blood pressure by circulatory renin angiotensin | GO:0001991 | 13 | 0.106 | |
| endocrine process | GO:0050886 | 39 | 0.106 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.106 | |
| triglyceride rich lipoprotein particle remodeling | GO:0034370 | 2 | 0.106 | |
| immune effector process | GO:0002252 | 321 | 0.106 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.104 | |
| defense response to other organism | GO:0098542 | 197 | 0.103 | |
| organelle assembly | GO:0070925 | 177 | 0.100 | |
| positive regulation of peptide secretion | GO:0002793 | 33 | 0.100 | |
| complement activation | GO:0006956 | 16 | 0.100 | |
| regulation of lipoprotein lipase activity | GO:0051004 | 4 | 0.100 | |
| endocrine system development | GO:0035270 | 98 | 0.099 | |
| ear development | GO:0043583 | 200 | 0.098 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.096 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.096 | |
| response to stilbenoid | GO:0035634 | 22 | 0.095 | |
| lipid transport | GO:0006869 | 98 | 0.095 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.095 | |
| maintenance of location | GO:0051235 | 89 | 0.095 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.094 | |
| alpha amino acid biosynthetic process | GO:1901607 | 15 | 0.093 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.093 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.093 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.093 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.092 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.092 | |
| angiogenesis | GO:0001525 | 201 | 0.092 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.092 | |
| opsonization | GO:0008228 | 3 | 0.090 | |
| positive regulation of activation of membrane attack complex | GO:0001970 | 2 | 0.089 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.089 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.089 | |
| organ growth | GO:0035265 | 117 | 0.089 | |
| humoral immune response | GO:0006959 | 57 | 0.088 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.088 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.087 | |
| collagen fibril organization | GO:0030199 | 32 | 0.086 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.086 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.085 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.085 | |
| liver development | GO:0001889 | 66 | 0.084 | |
| unsaturated fatty acid metabolic process | GO:0033559 | 31 | 0.084 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.084 | Human Mouse |
| tissue remodeling | GO:0048771 | 102 | 0.083 | |
| vitamin d3 metabolic process | GO:0070640 | 3 | 0.083 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.083 | |
| female gonad development | GO:0008585 | 71 | 0.083 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.083 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.081 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.081 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.081 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.079 | |
| spermatogenesis | GO:0007283 | 284 | 0.078 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.078 | |
| regulation of tube size | GO:0035150 | 57 | 0.078 | |
| cholesterol esterification | GO:0034435 | 3 | 0.077 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.076 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.075 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.074 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.074 | |
| protein secretion | GO:0009306 | 111 | 0.074 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.073 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.072 | |
| epithelium migration | GO:0090132 | 63 | 0.072 | |
| hormone secretion | GO:0046879 | 128 | 0.072 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.072 | Human |
| hormone metabolic process | GO:0042445 | 86 | 0.071 | |
| glycerolipid catabolic process | GO:0046503 | 16 | 0.071 | |
| negative regulation of carbohydrate metabolic process | GO:0045912 | 19 | 0.071 | |
| regulation of protein kinase c activity | GO:1900019 | 1 | 0.070 | |
| positive regulation of organ growth | GO:0046622 | 29 | 0.070 | |
| renal system process involved in regulation of systemic arterial blood pressure | GO:0003071 | 15 | 0.070 | |
| long chain fatty acid metabolic process | GO:0001676 | 26 | 0.070 | |
| regulation of renal output by angiotensin | GO:0002019 | 2 | 0.069 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.069 | |
| regulation of coagulation | GO:0050818 | 31 | 0.069 | Human Mouse |
| sterol transport | GO:0015918 | 38 | 0.068 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.068 | |
| glial cell differentiation | GO:0010001 | 131 | 0.068 | Human |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.068 | |
| mesonephros development | GO:0001823 | 97 | 0.067 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.066 | Human |
| cellular ion homeostasis | GO:0006873 | 165 | 0.066 | Human |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.065 | |
| placenta development | GO:0001890 | 140 | 0.065 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.064 | Human |
| lipid catabolic process | GO:0016042 | 69 | 0.064 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.064 | Human |
| mesonephric tubule development | GO:0072164 | 94 | 0.064 | |
| plasma lipoprotein particle organization | GO:0071827 | 11 | 0.064 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.064 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.063 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.063 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.063 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.063 | |
| regulation of ossification | GO:0030278 | 112 | 0.063 | |
| endocytosis | GO:0006897 | 168 | 0.062 | |
| response to inorganic substance | GO:0010035 | 96 | 0.062 | |
| trophoblast giant cell differentiation | GO:0060707 | 15 | 0.062 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.062 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.062 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.062 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.061 | |
| renal tubule development | GO:0061326 | 87 | 0.061 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.061 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.061 | |
| regulation of phosphatidylinositol 3 kinase signaling | GO:0014066 | 30 | 0.060 | |
| innate immune response | GO:0045087 | 157 | 0.060 | |
| lipid storage | GO:0019915 | 36 | 0.060 | |
| glial cell development | GO:0021782 | 54 | 0.060 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.060 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.059 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.058 | |
| kidney development | GO:0001822 | 213 | 0.058 | |
| glucocorticoid metabolic process | GO:0008211 | 9 | 0.058 | |
| multicellular organismal macromolecule metabolic process | GO:0044259 | 19 | 0.057 | Human |
| chemotaxis | GO:0006935 | 247 | 0.057 | |
| bone development | GO:0060348 | 120 | 0.057 | |
| regulation of cell motility | GO:2000145 | 236 | 0.057 | |
| very low density lipoprotein particle remodeling | GO:0034372 | 1 | 0.056 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.056 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.056 | Human |
| renal system process | GO:0003014 | 48 | 0.056 | |
| response to acid chemical | GO:0001101 | 111 | 0.056 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.055 | |
| plasminogen activation | GO:0031639 | 7 | 0.055 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.055 | |
| renin angiotensin regulation of aldosterone production | GO:0002018 | 3 | 0.055 | |
| retinoid metabolic process | GO:0001523 | 24 | 0.055 | |
| positive regulation of protein activation cascade | GO:2000259 | 2 | 0.054 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.054 | |
| protein lipid complex remodeling | GO:0034368 | 6 | 0.054 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.054 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.054 | |
| adiponectin activated signaling pathway | GO:0033211 | 4 | 0.053 | |
| dna metabolic process | GO:0006259 | 303 | 0.053 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.053 | |
| ureteric bud development | GO:0001657 | 94 | 0.053 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.052 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.052 | |
| gonad development | GO:0008406 | 141 | 0.052 | |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 34 | 0.052 | |
| cellular alcohol metabolic process | GO:0044107 | 3 | 0.052 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.052 | Human |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.052 | |
| hepatocyte growth factor receptor signaling pathway | GO:0048012 | 3 | 0.052 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.051 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.051 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.051 | |
| regulation of neuron death | GO:1901214 | 134 | 0.051 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.051 | |
| cellular response to lipid | GO:0071396 | 145 | 0.051 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.051 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.051 | |
| kidney epithelium development | GO:0072073 | 121 | 0.050 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.050 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.049 | |
| muscle tissue development | GO:0060537 | 308 | 0.049 | |
| collagen biosynthetic process | GO:0032964 | 7 | 0.048 | Human |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.047 | Human |
| epithelial cell proliferation | GO:0050673 | 174 | 0.047 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.047 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.046 | Human |
| regulation of vasculature development | GO:1901342 | 88 | 0.046 | |
| embryonic placenta development | GO:0001892 | 98 | 0.046 | |
| cell fate commitment | GO:0045165 | 210 | 0.046 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.046 | |
| axonogenesis | GO:0007409 | 274 | 0.045 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.045 | Human |
| regulation of protein localization | GO:0032880 | 231 | 0.045 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.045 | |
| positive regulation of phagocytosis | GO:0050766 | 26 | 0.044 | |
| astrocyte activation | GO:0048143 | 2 | 0.044 | |
| artery development | GO:0060840 | 53 | 0.044 | |
| stem cell differentiation | GO:0048863 | 268 | 0.044 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.044 | |
| negative regulation of cellular carbohydrate metabolic process | GO:0010677 | 19 | 0.044 | |
| calcitriol biosynthetic process from calciol | GO:0036378 | 3 | 0.044 | |
| regulation of complement activation | GO:0030449 | 7 | 0.044 | |
| tissue migration | GO:0090130 | 68 | 0.044 | |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.043 | |
| protein catabolic process | GO:0030163 | 221 | 0.043 | |
| regulation of defense response | GO:0031347 | 233 | 0.043 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.043 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.043 | |
| cholesterol transport | GO:0030301 | 38 | 0.043 | |
| arachidonic acid metabolic process | GO:0019369 | 14 | 0.043 | |
| organelle localization | GO:0051640 | 179 | 0.043 | |
| regulation of blood vessel size by renin angiotensin | GO:0002034 | 5 | 0.043 | |
| positive regulation of growth | GO:0045927 | 104 | 0.042 | |
| triglyceride catabolic process | GO:0019433 | 9 | 0.042 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.042 | |
| renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure | GO:0001999 | 6 | 0.042 | |
| response to chromate | GO:0046687 | 1 | 0.042 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.042 | |
| cellular biogenic amine metabolic process | GO:0006576 | 28 | 0.042 | |
| bone morphogenesis | GO:0060349 | 78 | 0.041 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.041 | |
| cation transport | GO:0006812 | 399 | 0.041 | Human |
| activation of membrane attack complex | GO:0001905 | 4 | 0.041 | |
| lipoprotein biosynthetic process | GO:0042158 | 33 | 0.041 | |
| response to insulin | GO:0032868 | 100 | 0.041 | |
| diterpenoid metabolic process | GO:0016101 | 24 | 0.041 | |
| regulation of lipoprotein metabolic process | GO:0050746 | 4 | 0.040 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.040 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.040 | |
| folic acid containing compound metabolic process | GO:0006760 | 3 | 0.040 | |
| negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902042 | 11 | 0.040 | |
| epithelial cell development | GO:0002064 | 159 | 0.040 | |
| inner ear receptor cell differentiation | GO:0060113 | 61 | 0.040 | |
| chromatin organization | GO:0006325 | 206 | 0.040 | |
| low density lipoprotein particle remodeling | GO:0034374 | 2 | 0.040 | |
| negative regulation of complement activation | GO:0045916 | 3 | 0.040 | |
| porphyrin containing compound metabolic process | GO:0006778 | 22 | 0.040 | |
| plasma membrane long chain fatty acid transport | GO:0015911 | 1 | 0.040 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.039 | |
| regulation of fatty acid biosynthetic process | GO:0042304 | 12 | 0.039 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.039 | |
| regionalization | GO:0003002 | 337 | 0.039 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.039 | |
| neuron migration | GO:0001764 | 122 | 0.039 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.038 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.038 | |
| positive regulation of protein maturation | GO:1903319 | 7 | 0.038 | |
| labyrinthine layer blood vessel development | GO:0060716 | 21 | 0.038 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.038 | |
| glucose homeostasis | GO:0042593 | 128 | 0.038 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.037 | Human |
| small molecule catabolic process | GO:0044282 | 71 | 0.037 | |
| lipoprotein catabolic process | GO:0042159 | 7 | 0.037 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.037 | |
| connective tissue development | GO:0061448 | 179 | 0.037 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.037 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.037 | |
| urogenital system development | GO:0001655 | 261 | 0.037 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.036 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.036 | |
| steroid esterification | GO:0034433 | 3 | 0.036 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.036 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.036 | |
| camera type eye development | GO:0043010 | 266 | 0.036 | |
| cytokine production | GO:0001816 | 319 | 0.036 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.036 | |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.035 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.035 | |
| adaptive immune response | GO:0002250 | 155 | 0.035 | |
| regulation of organ growth | GO:0046620 | 61 | 0.035 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.035 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.035 | |
| sensory perception | GO:0007600 | 245 | 0.035 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.035 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.035 | |
| cell growth | GO:0016049 | 130 | 0.035 | |
| response to testosterone | GO:0033574 | 3 | 0.035 | |
| female gamete generation | GO:0007292 | 74 | 0.035 | |
| ketone body biosynthetic process | GO:0046951 | 1 | 0.034 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.034 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.034 | Human |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.034 | |
| cellular response to metal ion | GO:0071248 | 31 | 0.034 | |
| multicellular organismal metabolic process | GO:0044236 | 28 | 0.034 | Human |
| organ regeneration | GO:0031100 | 2 | 0.034 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.034 | |
| fatty acid transmembrane transport | GO:1902001 | 1 | 0.034 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.033 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.033 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.033 | |
| endothelial cell migration | GO:0043542 | 44 | 0.033 | |
| high density lipoprotein particle remodeling | GO:0034375 | 4 | 0.033 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.033 | |
| protein activation cascade | GO:0072376 | 19 | 0.033 | |
| gluconeogenesis | GO:0006094 | 39 | 0.033 | |
| cartilage development | GO:0051216 | 140 | 0.033 | |
| phagocytosis | GO:0006909 | 66 | 0.033 | |
| nephron development | GO:0072006 | 109 | 0.033 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.033 | |
| muscle cell development | GO:0055001 | 133 | 0.032 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.032 | |
| response to estrogen | GO:0043627 | 24 | 0.032 | |
| positive regulation of leukocyte mediated immunity | GO:0002705 | 70 | 0.032 | |
| ovulation | GO:0030728 | 15 | 0.032 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.032 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.032 | |
| respiratory system development | GO:0060541 | 190 | 0.032 | |
| acetylcholine catabolic process | GO:0006581 | 1 | 0.031 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.031 | |
| gliogenesis | GO:0042063 | 141 | 0.031 | Human |
| platelet activation | GO:0030168 | 40 | 0.031 | |
| positive regulation of coagulation | GO:0050820 | 13 | 0.031 | Human |
| neuron death | GO:0070997 | 154 | 0.031 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.031 | |
| response to growth factor | GO:0070848 | 198 | 0.031 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.031 | |
| chondrocyte development | GO:0002063 | 24 | 0.030 | |
| very long chain fatty acid catabolic process | GO:0042760 | 2 | 0.030 | |
| learning or memory | GO:0007611 | 148 | 0.030 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.030 | |
| regulation of cell shape | GO:0008360 | 39 | 0.030 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.030 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.030 | |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 46 | 0.030 | |
| acute inflammatory response | GO:0002526 | 41 | 0.030 | |
| positive regulation of phosphatidylinositol 3 kinase signaling | GO:0014068 | 20 | 0.030 | |
| skin development | GO:0043588 | 220 | 0.030 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.029 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.029 | |
| multicellular organism growth | GO:0035264 | 161 | 0.029 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.029 | |
| heart process | GO:0003015 | 94 | 0.029 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.029 | |
| limb development | GO:0060173 | 166 | 0.029 | |
| short chain fatty acid catabolic process | GO:0019626 | 2 | 0.029 | |
| pallium development | GO:0021543 | 120 | 0.029 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.029 | |
| regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902041 | 22 | 0.029 | |
| learning | GO:0007612 | 98 | 0.029 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.029 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.029 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.029 | |
| response to peptide hormone | GO:0043434 | 127 | 0.029 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.028 | |
| negative regulation of protein activation cascade | GO:2000258 | 3 | 0.028 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.028 | |
| response to osmotic stress | GO:0006970 | 21 | 0.028 | |
| endothelium development | GO:0003158 | 45 | 0.028 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.028 | |
| negative regulation of serine type endopeptidase activity | GO:1900004 | 2 | 0.028 | |
| response to nutrient levels | GO:0031667 | 109 | 0.028 | |
| cell killing | GO:0001906 | 67 | 0.028 | |
| macromolecular complex remodeling | GO:0034367 | 6 | 0.028 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.028 | |
| positive regulation of fatty acid metabolic process | GO:0045923 | 8 | 0.028 | |
| biomineral tissue development | GO:0031214 | 64 | 0.028 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.028 | Human |
| phasic smooth muscle contraction | GO:0014821 | 8 | 0.027 | |
| dna endoreduplication | GO:0042023 | 4 | 0.027 | |
| locomotory behavior | GO:0007626 | 195 | 0.027 | |
| palate development | GO:0060021 | 76 | 0.027 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.027 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.027 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.027 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.027 | |
| blood vessel endothelial cell migration | GO:0043534 | 23 | 0.027 | |
| positive regulation of blood pressure | GO:0045777 | 21 | 0.027 | |
| response to steroid hormone | GO:0048545 | 56 | 0.027 | |
| protein glycosylation | GO:0006486 | 55 | 0.026 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.026 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.026 | |
| organelle fission | GO:0048285 | 170 | 0.026 | |
| exocrine system development | GO:0035272 | 45 | 0.026 | |
| positive regulation of macrophage derived foam cell differentiation | GO:0010744 | 4 | 0.026 | |
| acylglycerol catabolic process | GO:0046464 | 11 | 0.026 | |
| striated muscle cell development | GO:0055002 | 125 | 0.026 | |
| naphthalene containing compound metabolic process | GO:0090420 | 1 | 0.026 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.026 | |
